June Sherie Almenoff

Companies

• Actinium Pharmaceuticals, Inc.Board member Nov 5, 2024 to now¹
• Avalo Therapeutics, Inc.Board member Nov 12, 2021 to now²
• TENAX THERAPEUTICS, INC.Board member Jun 15, 2021 to now³
• BRAINSTORM CELL THERAPEUTICS INC.Board member Feb 28, 2017 to Dec 17, 2021⁴
• 9 METERS BIOPHARMA, INC.Chief operating officer Mar 19, 2018 to Aug 28, 2018⁵
• NeuBase Therapeutics, Inc.Board member Jun 24, 2013 to Oct 18, 2017⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAvalo Therapeutics, Inc. AVTX4,167 shares⁷$48.3K at $11.58Apr 1, 2025
• APActinium Pharmaceuticals, Inc. ATNM18,000 shares⁸$24.2K at $1.34Sep 2, 2026
• BCBRAINSTORM CELL THERAPEUTICS INC. BCLI13,175 shares⁹$10.2K at $0.78Dec 17, 2021
• TTTENAX THERAPEUTICS, INC. TENX3,986 shares¹⁰$6.1K at $1.52Jan 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Granted 18,000 shares of Actinium Pharmaceuticals, Inc.⁸
• Nov 18, 2025Bought 1,900 shares at $7.52 of TENAX THERAPEUTICS, INC.¹¹
• Nov 18, 2025Bought 1,900 shares at $7.52 of TENAX THERAPEUTICS, INC.¹²
• Nov 17, 2025Bought 93 shares at $7.15 of TENAX THERAPEUTICS, INC.¹¹
• Nov 17, 2025Bought 93 shares at $7.15 of TENAX THERAPEUTICS, INC.¹²
• Mar 28, 2025Exercised options 3,167 shares of Avalo Therapeutics, Inc.⁷
• Nov 13, 2024Bought 500 shares at $13.00 of Avalo Therapeutics, Inc.¹³
• Nov 12, 2024Bought 500 shares at $12.50 of Avalo Therapeutics, Inc.¹³
• Dec 15, 2021Granted 2,000 shares of BRAINSTORM CELL THERAPEUTICS INC.⁹
• Dec 10, 2021Granted 2,000 shares of BRAINSTORM CELL THERAPEUTICS INC.¹⁴